A first prospective study reported that a Chinese-developed sequencing assay measuring donor-derived cell-free DNA can detect acute heart transplant rejection using a defined threshold. Researchers report a 0.33% cutoff for distinguishing rejection, offering a potential noninvasive alternative to routine biopsy workflows for transplant monitoring.